In recognition of Sickle Cell Disease Association of America (SCDAA), Inc.’s 50th anniversary, we have launched this limited, three-part speaker series, Masterclass on Sickle Cell Disease. Leading experts in sickle cell disease focus on novel concepts surrounding disease-modifying and curative therapies and their impact on those living with sickle cell disease. The goal is to approach key sickle cell topics with a fresh, innovative perspective through discussions that have not yet been had. Learn more about the series here.

Sponsored by Pfizer, SCDAA’s Masterclass Speaker Series will shine a light on sickle cell disease throughout the year.


Seminar One

Gene Therapy: A Journey Forward

Our panelists, including SCDAA Chief Medical Officer Lewis Hsu, M.D., and Edward Donnell Ivy, M.D., SCDAA vice chief medical officer, explore the role of gene therapy in our journey forward. The discussion is moderated by Andrew Campbell, M.D., director of the Children’s National Comprehensive Sickle Cell Disease Program.


Seminar Two
All Things Considered – SCD Treatment: A Personal Choice

Co-hosts Teonna Woolford and Dr. Wanda Whitten-Shurney will discuss the many considerations that go into making a decision to choose disease modifying treatments or curative therapies. Panelists will include speakers who share their lived SCD experiences, the choices they made and why.


Seminar Three
The Perfect Red Blood Cell: An SC Dream Redefined

This session was held live at our Annual National Convention in October 2023. The session was moderated by Kim Smith-Whitley, M.D., and featured panelists Vence Bonham, J.D., Tangela Roberts, Teonna Woolford and Andre Harris.